REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Goldline Pharmaceutical Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Goldline Pharmaceutical Limited Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Goldline Pharmaceutical Limited is an unlisted company, incorporated on 02/08/2004. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U51397MH2004PLC147806 and registration number is 147806.

Headquarters
103 F-1 Leela Apartment Shilpa Hsg Society Near Saptagiri Nagar Shanidham Narendra Nagar Nagpur In-Mh In 440015
Nagpur; Maharashtra; Postal Code: 440015

Contact Details: Purchase the Goldline Pharmaceutical Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Goldline Pharmaceutical Limited report to view the information.
Financial Auditors:
Purchase the Goldline Pharmaceutical Limited report to view the information.
Incorporation Date:
August 02, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
39.85%
Purchase this report to view the information.
39.85%
Purchase this report to view the information.
9.78%
Company Performance
Financial values in the chart are available after Goldline Pharmaceutical Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
18.61%▲
Total operating revenue
18.61%▲
Operating profit (EBIT)
29.75%▲
EBITDA
31.9%▲
Net Profit (Loss) for the Period
46.33%▲
Total Assets
7.39%▲
Total Equity
15.04%▲
Operating Profit Margin (ROS)
1.71%▲
Net Profit Margin
1.91%▲
Return on Equity (ROE)
5.9%▲
Debt/Equity
-26.9%▼
Quick Ratio
-0.02%▼
Cash Ratio
0.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo